stockrowEnsysce Biosciences, Inc. (ENSC) vs VistaGen Therapeutics, Inc. (VTGN)
- Ensysce Biosciences, Inc. ENSC 0.34 −5.56%
- VistaGen Therapeutics, Inc. VTGN 0.17 0.00%
Ensysce Biosciences, Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and VistaGen Therapeutics, Inc. are of similar size ($7.3M and $7.0M). VistaGen Therapeutics, Inc. grew revenue faster over the last twelve months: 287.2% against −39.3%. Ensysce Biosciences, Inc. has the higher net margin (−280.5% vs −2,703.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Ensysce Biosciences, Inc. leads on 9 and VistaGen Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ENSC | VTGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (281.32%) | (2,785.69%) | 0.00% |
| Net margin | (280.49%) | (2,703.72%) | 0.00% |
| Free cash flow margin | (196.76%) | (2,490.88%) | 0.00% |
| Return on equity | (1,295.01%) | (166.46%) | (51.96%) |
| Return on assets | (295.92%) | (129.22%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack